A deformability-based biochip for precise label-free stratification of metastatic subtypes using deep learning.
Source check: Source checked. Not independent scientific confirmation.
Finding: Yolov5, Deep SORT and ResUNet++ detect, track and segment cells to quantify deformability in a microfluidic assay. The source reports cell-line classification and pre/post-hypoxia comparisons; evidence is in vitro and does not establish patient-level diagnosis. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: Yolov5, Deep SORT and ResUNet++ detect, track and segment cells to quantify deformability in a microfluidic assay.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Yolov5, Deep SORT and ResUNet++ detect, track and segment cells to quantify deformability in a microfluidic assay.
- Test and result
- Yolov5, Deep SORT and ResUNet++ detect, track and segment cells to quantify deformability in a microfluidic assay. The source reports cell-line classification and pre/post-hypoxia comparisons; evidence is in vitro and does not establish patient-level diagnosis.
- Limitation / still unknown
- The source reports cell-line classification and pre/post-hypoxia comparisons; evidence is in vitro and does not establish patient-level diagnosis.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10539402/ · https://doi.org/10.1038/s41378-023-00577-1 · https://europepmc.org/article/MED/37780810
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.